These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 28557723

  • 1. Microcystic Lymphatic Malformation Successfully Treated With Topical Rapamycin.
    García-Montero P, Del Boz J, Sanchez-Martínez M, Escudero Santos IM, Baselga E.
    Pediatrics; 2017 May; 139(5):. PubMed ID: 28557723
    [Abstract] [Full Text] [Related]

  • 2. Preliminary experience of percutaneous intralesional bleomycin injection for the treatment of orbital lymphatic-venous malformation refractory to surgery.
    Shen CY, Wu MC, Tyan YS, Ou CH, Chen TY, Wong HF.
    Clin Radiol; 2012 Feb; 67(2):182-4. PubMed ID: 22018802
    [No Abstract] [Full Text] [Related]

  • 3. Intralesional injection of Pingyangmycin for vascular malformations in oral and maxillofacial regions: an evaluation of 297 consecutive patients.
    Zheng JW, Yang XJ, Wang YA, He Y, Ye WM, Zhang ZY.
    Oral Oncol; 2009 Oct; 45(10):872-6. PubMed ID: 19628423
    [Abstract] [Full Text] [Related]

  • 4. A case of microcystic lymphatic malformation successfully treated with topical sirolimus.
    Çalışkan E, Altunel CT, Özkan CK, Tunca M.
    Dermatol Ther; 2018 Sep; 31(5):e12673. PubMed ID: 30133999
    [Abstract] [Full Text] [Related]

  • 5. Intralesional bleomycin injection in management of low flow vascular malformations in children.
    Mohan AT, Adams S, Adams K, Hudson DA.
    J Plast Surg Hand Surg; 2015 Apr; 49(2):116-20. PubMed ID: 25204206
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series.
    Le Sage S, David M, Dubois J, Powell J, McCuaig CC, Théorêt Y, Kleiber N.
    Pediatr Dermatol; 2018 Jul; 35(4):472-477. PubMed ID: 29790593
    [Abstract] [Full Text] [Related]

  • 7. The Use of Sirolimus for Treatment of Orbital Lymphatic Malformations: A Systematic Review.
    Shoji MK, Shishido S, Freitag SK.
    Ophthalmic Plast Reconstr Surg; 2020 Jul; 36(3):215-221. PubMed ID: 31990892
    [Abstract] [Full Text] [Related]

  • 8. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
    Ozeki M, Nozawa A, Yasue S, Endo S, Asada R, Hashimoto H, Fukao T.
    Orphanet J Rare Dis; 2019 Jun 13; 14(1):141. PubMed ID: 31196128
    [Abstract] [Full Text] [Related]

  • 9. Topical rapamycin and microcystic lymphatic malformations.
    Gu Y, Sebaratnam DF.
    J Am Acad Dermatol; 2024 Jan 13; 90(1):e29-e30. PubMed ID: 37717734
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series.
    Dodds M, Tollefson M, Castelo-Soccio L, Garzon MC, Hogeling M, Hook K, Boull C, Maguiness S.
    Pediatr Dermatol; 2020 Mar 13; 37(2):272-277. PubMed ID: 31957126
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Management of periorbital microcystic lymphatic malformation with blepharoptosis: Surgical treatment combined with intralesional bleomycin injection.
    Yang X, Jin Y, Lin X, Chen H, Ma G, Hu X, Qiu Y, Yu W, Chang L, Wang T.
    J Pediatr Surg; 2015 Aug 13; 50(8):1393-7. PubMed ID: 25783292
    [Abstract] [Full Text] [Related]

  • 14. Intralesional bleomycin injection treatment for vascular birthmarks: a 5-year experience at a single United Kingdom unit.
    Sainsbury DCG, Kessell G, Fall AJ, Hampton FJ, Guhan A, Muir T.
    Plast Reconstr Surg; 2011 May 13; 127(5):2031-2044. PubMed ID: 21532430
    [Abstract] [Full Text] [Related]

  • 15. Sirolimus in the Treatment of Vascular Anomalies.
    Triana P, Dore M, Cerezo VN, Cervantes M, Sánchez AV, Ferrero MM, González MD, Lopez-Gutierrez JC.
    Eur J Pediatr Surg; 2017 Feb 13; 27(1):86-90. PubMed ID: 27723921
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of bleomycin sclerotherapy for microcystic lymphatic malformation.
    Chaudry G, Guevara CJ, Rialon KL, Kerr C, Mulliken JB, Greene AK, Fishman SJ, Boyer D, Alomari AI.
    Cardiovasc Intervent Radiol; 2014 Dec 13; 37(6):1476-81. PubMed ID: 24938907
    [Abstract] [Full Text] [Related]

  • 18. Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial.
    Leducq S, Caille A, Barbarot S, Bénéton N, Bessis D, Boccara O, Bursztejn AC, Chiaverini C, Dompmartin A, Droitcourt C, Gissot V, Goga D, Guibaud L, Herbreteau D, Le Touze A, Léauté-Labrèze C, Lorette G, Mallet S, Martin L, Mazereeuw-Hautier J, Phan A, Plantin P, Quéré I, Vabres P, Bourgoin H, Giraudeau B, Maruani A, Groupe de Recherche de la Société Française de Dermatologie Pédiatrique.
    Trials; 2019 Dec 17; 20(1):739. PubMed ID: 31847908
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.